ArQule reports net loss of $7.

Our earlier clinical-stage programs are centered on ARQ 092, an Akt inhibitor, and ARQ 087, an FGFR inhibitor, said Mr. Pucci. Phase 1 trials with both these items are nearing the achievement of maximum tolerated dose, and we plan to announce data from these trials this season later. Related StoriesNew results reveal association between colorectal tumor and melanoma medication treatmentStudy shows rare HER2 missense mutations usually do not spread breasts cancer on the ownSausages With Antioxidants From Berries To Prevent CancerRevenues and Expenses THE BUSINESS reported research and development revenue of $2,676,000 for the quarter ended March 31, 2014, weighed against $5,661,000 for the quarter ended March 31, 2013.To learn more on obesity styles, tables, including an animated map, visit For more information about CDC’s initiatives in the fight obesity or to learn more about nutrition, exercise, and maintaining a wholesome weight, visit.

China praised for transparency during bird flu outbreak SHANGHAIAfter a lethal and new strain of bird flu, H7N9, emerged in Shanghai fourteen days ago, the government of China’s bustling financial capital responded with live updates on a Twitter-like microblog. It’s a starkly different approach than a decade ago, when Chinese officials silenced reporting as a deadly pneumonia later known as SARS killed dozens in the south.